BROTZMAN RICHARD W 4
4 · NANOPHASE TECHNOLOGIES CORPORATION · Filed Nov 12, 2003
Insider Transaction Report
Form 4
BROTZMAN RICHARD W
VP - Research & Development
Transactions
- Sale
Common Stock
2003-11-07$6.14/sh−10,000$61,428→ 0 total - Exercise/Conversion
Common Stock
2003-11-07$1.73/sh+10,000$17,270→ 10,000 total
Holdings
- 69,480
Stock Option (right to buy)
Exercise: $3.89From: 1997-11-07Exp: 2006-11-07→ Common Stock (69,480 underlying) - 22,500
Stock Option (right to buy)
Exercise: $7.69From: 2001-05-24Exp: 2010-05-24→ Common Stock (22,500 underlying) - 40,600
Stock Option (right to buy)
Exercise: $3.81From: 1999-07-31Exp: 2008-07-31→ Common Stock (40,600 underlying) - 15,000
Stock Option (right to buy)
Exercise: $1.75From: 2000-07-27Exp: 2009-07-27→ Common Stock (15,000 underlying) - 2,100
Stock Option (right to buy)
Exercise: $1.73From: 1997-03-01Exp: 2006-03-01→ Common Stock (49,215 underlying) - 20,000
Stock Option (right to buy)
Exercise: $10.88From: 2002-01-26Exp: 2011-01-26→ Common Stock (20,000 underlying)
Footnotes (3)
- [F1]Subject to certain restrictions, beginning on this date, options vest in five equal installments.
- [F2]Subject to certain restrictions, 51,485 of these options vest in five equal annual installments beginning on 11/07/1997, with the remainder vesting on 11/07/2004.
- [F3]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.